CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Bio Plus Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Bio Plus Co Ltd
227, Dogok-ro, Gangnam-gu
Phone: +82 317421898p:+82 317421898 SEONGNAM, 13209  South Korea Ticker: 099430099430
This company was Merged or Acquired on 2/15/2023.
This is a Subsidiary, click here for the Parent Company
Business Summary
Bio Plus Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of biomedical devices. The Company mainly researches, develops, produces, and sells hyaluronic acid application products such as fillers, anti-adhesion agents, joint tissue repair agents, and bladder tissue repair agents. The Company also develops, produces, and supplies products such as botulinum toxin, obesity and diabetes treatments, etc. The Company also develops biocosmetic products.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202412/31/2024Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
3842 Orthopedic, prosthetic, and surgical appliances and supplies
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Hyun KyuJung

General Information
Outstanding Shares: 58,503,791 (As of 3/28/2025)
Shareholders: 32,848
Stock Exchange: KDQ
Fax Number: +82 317411897


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, April 19, 2025